Centuple Global Limited held its 35th Annual General Meeting on September 30, 2026, via Video Conferencing and Other Audio Visual Means. The meeting focused on adopting the audited standalone financial statements for FY26 and approving the appointment of a new woman independent director.

The proceedings were chaired by Shubham Chaudhary, the Managing Director and Chairperson of the company. The meeting commenced at 11:00 am with the requisite quorum present, as confirmed by the chairperson in accordance with Ministry of Corporate Affairs circulars regarding virtual meetings.

Resolutions passed

The agenda included ordinary business regarding the adoption of financial reports and special business concerning board appointments. The following key items were considered:

Ms. Neha Varshney (DIN: 08236373) was proposed for appointment as the Woman Independent Director of the company. This proposal required a special resolution for approval by the shareholders.

Meeting details and voting

All directors, the Company Secretary, Compliance Officer, Statutory Auditors, Secretarial Auditors, Scrutinizer, and Internal Auditor attended the meeting virtually. No registered speaker shareholders were present to address the members during the open floor session.

Voting on the resolutions was conducted through electronic means. Members who had not yet voted through remote e-voting were permitted to vote during the meeting. The final results, along with the Scrutinizer’s report, will be declared upon receipt and submitted to BSE Limited, where the company’s shares are listed.

Centuple Global Limited appointed Ajay Agarwal as an additional whole time director on September 24, 2026. The decision was taken during a board meeting held the same day, subject to member approval in an upcoming Extra Ordinary General Meeting.

Appointment details and profile

Agarwal brings approximately 30 years of experience across FMCG, dairy, laboratory solutions, and real estate sectors. His career has focused heavily on the dairy and milk-products industry, along with laboratory chemicals and machinery used in these fields. He is credited with strong capabilities in commercial strategy, procurement, sales development, and cost efficiency.

The company confirmed that Agarwal is not related to any other director and holds no shares in the company. Furthermore, he is not debarred from holding the office of director by any regulatory authority.

Board meeting outcomes

The board meeting commenced at 12:00 pm and concluded at 2:10 pm. The primary agenda item was the consideration and approval of Agarwal's appointment. The company disclosed these details to BSE Limited pursuant to Regulation 33 of the SEBI (LODR) Regulations, 2015.

The appointment is currently effective as an additional director role. Final confirmation will depend on the ratification by shareholders during the ensuing Extra Ordinary General Meeting.